This inventor holds 2 USPTO granted patents. Top assignee: Jiangsu Kanion Pharmaceutical Co., Ltd.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Yongxiang Wang: Innovator in Pharmaceutical Composition
Introduction
Yongxiang Wang is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical compositions, particularly focusing on the therapeutic effects of ginkgo diterpene lactone compositions. With a total of two patents to his name, Wang's work has implications for neurological health and mood improvement.
Latest Patents
Wang's latest patents include a ginkgo diterpene lactone composition that demonstrates the ability to lower neurological function scores in cerebral ischemia-reperfusion rat models. This composition not only reduces the cerebral ischemia area and water content after brain tissue edema but also improves superoxide dismutase (SOD) activity while decreasing malondialdehyde (MDA) content. Additionally, it inhibits rabbit platelet aggregation induced by PAF and ADP at various time points, effectively reducing the maximum aggregation rate. Another significant patent focuses on the same ginkgo diterpene lactone composition, which has been shown to improve depressive states. This composition can prolong tail flick and swimming interval times in mice, as well as increase the frequency of escaping from electric shocks. The addition of specific ginkgolides enhances the overall effectiveness of the composition in alleviating depressive symptoms.
Career Highlights
Wang is currently associated with Jiangsu Kanion Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceutical research. His work is characterized by a strong emphasis on the therapeutic potential of natural compounds, particularly those derived from ginkgo.
Collaborations
Wang collaborates with notable colleagues such as Wei Xiao and Xiujuan Chang, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Yongxiang Wang's contributions to the field of pharmaceutical compositions highlight the potential of natural compounds in treating neurological and mood disorders. His innovative work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile